Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Periscope Analytics

Periscope Analytics focuses on event-driven trades across Asia Pacific and provides comprehensive, timely and systematic coverage of index changes to major Asia Pacific indices in a structured manner.

The analysis includes forecasted inclusions and exclusions to all major Asian indices that have significant amount of tracking assets, including estimates of passive buy/sell flow on the stocks. The service also provides commentary and impact of market consultations, ground rule changes, and other events (IPOs, spin-offs, M&A) that could lead to index changes and passive flow.

Periscope Analytics works with multi-strategy hedge funds, proprietary trading firms, stat arb trading groups and long-only investors that invest and trade in the Asia Pacific region with the data being used to trade index rebalances, avoid pre-positioning and passive flow, and to time entry into and exit from stocks.

Event-Driven Trades Across Asia Pacific

Event-Driven

<ul>
<li>There are 18 changes for the SSE180 Index that will be implemented at the close of trading on 9 June.</li>
<li>The impact on the stocks is small but this is not a widely tracked index, so there could still be opportunities for some high risk/reward basket trades.</li>
<li>With Northbound Stock Connect eligibility no longer drawing on the SSE180 Index constituents, the index could lose relevance over time.</li>
</ul>


There are 18 changes for the SSE180 Index that will be implemented at the close of trading on 9 June.
The impact on the stocks is small but this is not a widely tracked index, so there could still be opportunities for some high risk/reward basket trades.
With Northbound Stock Connect eligibility no longer drawing on the SSE180 Index constituents, the index could lose relevance over time.


SSE180 Index Rebalance: Small Impact but Not Widely Tracked

Articles from Caixin Global, Caixin Global

Caixin Global

Articles from Caixin Global

Caixin is a media group dedicated to providing financial and business news through periodicals, online content, mobile apps, conferences, books and TV/video programs. Caixin aims to blaze a trail that helps traditional media prosper in the new media age through integrated multimedia platforms.

News from Caixin

Cross Asset Strategy

<ul>
<li>Some state-owned drugmakers have moved to round-the-clock production and ramped up overseas procurement after the sudden reversal of China’s “zero-Covid” policy cleared pharmacy shelves of fever and cough medicines.</li>
<li>After acute outbreaks in Beijing and Guangzhou overran Covid controls, demand has exploded across the country for so-called “anti-epidemic drugs,”</li>
<li>According to data provided to Caixin by JD Health, the pharmacy platform saw an 18-fold spike in sales of anti-epidemic drugs in the week to Dec. 4, compared to the week to Nov. 4.</li>
</ul>


Some state-owned drugmakers have moved to round-the-clock production and ramped up overseas procurement after the sudden reversal of China’s “zero-Covid” policy cleared pharmacy shelves of fever and cough medicines.
After acute outbreaks in Beijing and Guangzhou overran Covid controls, demand has exploded across the country for so-called “anti-epidemic drugs,”
According to data provided to Caixin by JD Health, the pharmacy platform saw an 18-fold spike in sales of anti-epidemic drugs in the week to Dec. 4, compared to the week to Nov. 4.


China’s State Drugmakers Scramble to Stock Pharmacy Shelves Amid Run on Covid Medicines

<ul><li>In Depth: China’s pension insurers told to stop pursuing quick and risky profits</li><li>China Meheco links up with Pfizer to market Covid pill</li><li>China must address gender imbalance to tackle demographic crisis, Nobel laureate says</li></ul>

In Depth: China’s pension insurers told to stop pursuing quick and risky profitsChina Meheco links up with Pfizer to market Covid pillChina must address gender imbalance to tackle demographic crisis, Nobel laureate says

CX Daily: China’s Pension Insurers Told to Stop Pursuing Quick and Risky Profits

<ul><li>Sanctions: Sanctions on Russia sound alarm for Chinese banks</li><li>Paxlovid: China Meheco confirms Pfizer talks on selling Paxlovid in China</li><li>Fund: Caixin Explains: Why China’s creating a financial security fund. </li></ul>

Sanctions: Sanctions on Russia sound alarm for Chinese banksPaxlovid: China Meheco confirms Pfizer talks on selling Paxlovid in ChinaFund: Caixin Explains: Why China’s creating a financial security fund. 

CX Daily: Sanctions on Russia Sound Alarm for Chinese Banks

M&A Reporting, CTFN

Jonathan Spitzer

M&A Reporting

CTFN

Bringing the marketplace leading coverage of mergers, events, and major corporate actions, CTFN has a team of seasoned reporters from Los Angeles to London, publishing news that advances stories that matter to event-driven investors and deal professionals.

The top 20 Chinese pharmaceutical companies are seeking US acquisitions, taking advantage of a lull in healthcare M&amp;A because of regulatory uncertainty to find bargains, said a source familiar with the matter and a sector banker.

The top 20 Chinese pharmaceutical companies are seeking US acquisitions, taking advantage of a lull in healthcare M&amp;A because of regulatory uncertainty to find bargains, said a source familiar with the matter and a sector banker.

Top Chinese Pharma Companies Seeking Deals in the US

China

China Meheco Co Ltd operates an import and export business. The Company trades pharmaceutical products, paper making machinery, and aluminum extruders. CNTIC Trading also imports patent technologies and industrial techniques.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China Meheco Co Ltd A (600056 CH)

SSE180 Index Rebalance: Small Impact but Not Widely Tracked

There are 18 changes for the SSE180 Index in June. The index is not widely tracked and there could be opportunities for long/short basket trades...

Brian Freitas

China’s State Drugmakers Scramble to Stock Pharmacy Shelves Amid Run on Covid Medicines

According to data provided to Caixin by JD Health, the pharmacy platform saw an 18-fold spike in sales of anti-epidemic drugs in the week to Dec....

Caixin Global

CX Daily: China’s Pension Insurers Told to Stop Pursuing Quick and Risky Profits

In Depth: China’s pension insurers told to stop pursuing quick and risky profits. China Meheco links up with Pfizer to market Covid pill

Caixin Global

CX Daily: Sanctions on Russia Sound Alarm for Chinese Banks

Sanctions: Sanctions on Russia sound alarm for Chinese banks. Paxlovid: China Meheco confirms Pfizer talks on selling Paxlovid in China

Caixin Global

Top Chinese Pharma Companies Seeking Deals in the US

The top 20 Chinese pharmaceutical companies are seeking US acquisitions, taking advantage of a lull in healthcare M&A because of regulatory...

CTFN

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)